A

Ataraxis.ai

AI-powered prognostic test for breast cancer

Member of Technical Staff - Bayesian Statistics

AI ResearchConfirmed live in the last 24 hours
Full-timeNew York, NY, USA$100k - $300k /yrIn-person

About the Job

Requirements

  • A PhD degree in statistics or machine learning.
  • Excellent knowledge of Bayesian statistics, including Gaussian processes and Bayesian clinical trial design.
  • Excellent understanding of core machine learning concepts.
  • Excellent knowledge of the foundations of statistics, linear algebra, probability, and machine learning.
  • Excellent skills in Python and PyTorch.
  • Experience applying Bayesian statistics to uncertainty quantification in deep learning and model explainability.
  • Experience in deep learning.

Responsibilities

  • Design and implement novel Bayesian statistics methods.
  • Translate machine learning papers into production-ready code.
  • Build robust model evaluation frameworks.
  • Disseminate results by co-authoring research papers and abstracts.
  • Collaborate with a multidisciplinary team of engineers and scientists.
  • Co-mentor junior members of the team.

Desired Qualifications

  • Strong preference is given to candidates with papers in A* conferences (e.g., ICML, ICLR, NeurIPS, CVPR) or top-tier statistics journals.
  • Experience in self-supervised learning, survival analysis, multi-modal learning, domain adaptation, causal inference, model interpretability, or computational pathology is a bonus.

About the Company

Ataraxis.ai

AI-powered prognostic test for breast cancer

Ataraxis.ai creates precision medicine tools for cancer care using artificial intelligence. Its first product, Ataraxis Breast, is an AI-native prognostic test for breast cancer designed to predict patient outcomes more accurately and help doctors personalize treatment plans. Results are delivered quickly, within one business day, through a physician portal or to clinicians. The company differentiates itself by offering an AI-driven prognostic test that aims to set a new standard in molecular diagnostics rather than relying on traditional methods alone, with a focus on rapid, actionable insights for oncology. The goal is to improve how cancer treatment decisions are made by providing fast, data-driven prognostic information to physicians and healthcare providers.

Company size
11-50
Company stage
Series A
Total funding
$44.8M
Headquarters
New York City, New York
Founded
2023

Recently Posted Jobs

Explore more opportunities at Ataraxis.ai

See more jobs